Login to Your Account



Cash-Rich NicOx Surges on $31M Altacor Acquisition Deal

By Cormac Sheridan
Staff Writer

Wednesday, March 28, 2012
Shares in NicOx SA surged almost 35 percent last week on news that the company had taken its first concrete step toward becoming a late-stage development and commercial player in opthalmology by entering a cash-and-shares acquisition agreement with Altacor Ltd. that could be worth as much as £19.5 million (US$30.9 million).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription